This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Svetkey, L. P. Articles by Klotman, P. E. Search for Related Content PubMed PubMed Citation Articles by Svetkey, L. P. Articles by Klotman, P. E.

Hypertension, Vol 14, 247-257, Copyright © 1989 by American Heart Association

ARTICLES

Prospective analysis of strategies for diagnosing renovascular hypertension

LP Svetkey, SI Himmelstein, NR Dunnick, RH Wilkinson Jr, RR Bollinger, RL McCann, EM Beytas and PE Klotman
Department of Medicine, Duke University Medical Center, Durham, NC 27710.

Renovascular hypertension is a potentially curable form of high blood pressure. However, it is unclear how best to select patients who are likely to have renovascular hypertension, what diagnostic strategy to use in these selected patients, and how to predict the hemodynamic significance of a renal artery stenosis. We determined the prevalence of renovascular hypertension in adults who exhibited suggestive clinical features. In these clinically selected patients, we then determined the test characteristics of various diagnostic and potential screening tests. Renovascular hypertension was diagnosed if correction of renal artery stenosis resulted in decreased blood pressure. Of the 66 hypertensive adults evaluated, 11 (16.7%) had renovascular hypertension. Captopril-stimulated peripheral renin activity detected renovascular hypertension with 73% sensitivity, 72% specificity, 38% positive predictive value, and 92% negative predictive value. Less optimal combinations of sensitivity and specificity were found for differential glomerular filtration rate renography, differential effective renal plasma flow renography, and selective renal vein renin ratios, each performed after a single dose of captopril. Intravenous digital subtraction renal angiography detected all patients with renovascular hypertension and was normal in 71% of patients with essential hypertension. To evaluate potential screening tests for renovascular hypertension, we calculated predictive values applied to a low prevalence population. If the observed sensitivities and specificities apply to a population with 5% prevalence of renovascular hypertension, captopril-stimulated peripheral renin would have a positive predictive value of 12% and a negative predictive value of 98%. In 16 patients with known renal artery stenosis, neither the captopril-stimulated renal vein renin ratio nor captopril-stimulated differential renography accurately predicted blood pressure response to correction of the stenosis. We conclude that clinical criteria can identify a subgroup with 16.7% prevalence of renovascular hypertension. In this high prevalence group, intravenous digital subtraction renal angiography will identify virtually all patients with renovascular hypertension, and a normal study will be sufficient to exclude renovascular hypertension. In unselected hypertensive patients, screening with captopril-stimulated peripheral renin activity may be the most useful and efficient procedure for identification of patients with renovascular hypertension. Functional tests do not accurately predict the hemodynamic significance of a renal artery stenosis.

This article has been cited by other articles:

				G. Soulez, E. Therasse, S. D. Qanadli, D. Froment, M. Leveille, V. Nicolet, S. Turpin, M.-F. Giroux, M. C. Guertin, and V. L. Oliva Prediction of Clinical Response After Renal Angioplasty: Respective Value of Renal Doppler Sonography and Scintigraphy Am. J. Roentgenol., October 1, 2003; 181(4): 1029 - 1035. [Abstract] [Full Text] [PDF]

				J. F. Reckelhoff and J. C. Romero Role of oxidative stress in angiotensin-induced hypertension Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R893 - R912. [Abstract] [Full Text] [PDF]

				S. D. Sarkar, D. N. Siegel, G. Soulez, and V. L. Oliva Invited Commentary Authors' Response RadioGraphics, September 1, 2000; 20(5): 1368 - 1372. [Full Text] [PDF]

				K. A. Collins and R. J. Gusberg Current Perspectives on the Role of Captopril Imaging in the Diagnosis of Renovascular Disease Perspectives in Vascular Surgery and Endovascular Therapy, January 1, 2000; 13(1): 43 - 69. [Abstract] [PDF]

				M. Takata, K. Yoshida, F. Tomoda, S. Oh-hashi, H. Ueno, K. Yasumoto, H. Iida, and S. Sasayama Diagnostic Value of Captopril Test in Hypertensive Patients with Renal Artery Stenosis Angiology, March 1, 1994; 45(3): 181 - 186. [Abstract] [PDF]

				W. J. Elliott, W. B. Martin, and M. B. Murphy Comparison of Two Noninvasive Screening Tests for Renovascular Hypertension Arch Intern Med, March 22, 1993; 153(6): 755 - 764. [Abstract] [PDF]

				R. A. Davidson and C. S. Wilcox Newer Tests for the Diagnosis of Renovascular Disease JAMA, December 16, 1992; 268(23): 3353 - 3358. [Abstract] [PDF]

				S. J. Mann and T. G. Pickering Detection of Renovascular Hypertension: State of the Art: 1992 Ann Intern Med, November 15, 1992; 117(10): 845 - 853. [Abstract] [PDF]

				C. T. Postma, A. H. A. M. van Oijen, J. O. Barentsz, T. de Boo, W. H. L. Hoefnagels, F. H. M. Corstens, and T. Thien The Value of Tests Predicting Renovascular Hypertension in Patients With Renal Artery Stenosis Treated by Angioplasty Arch Intern Med, August 1, 1991; 151(8): 1531 - 1535. [Abstract] [PDF]